Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1992-10-30
1995-04-18
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514184, 514188, 514400, 514471, A61K 3324, A61K 31555, A61K 31415, A61K 3134
Patent
active
054076889
ABSTRACT:
The present invention relates to pharmaceutical compositions useful for treating or preventing gastrointestinal disorders. These compositions comprise a campylobacter-inhibiting antimicrobial agent such as nitrofurantoin and bismuth subsalicylate, and a histamine-2 receptor blocking anti-secretory agent such as cimetidine.
The present invention further relates to methods for treating or preventing gastrointestinal disorders in humans or lower animals by administering a campylobacter-inhibiting antimicrobial agent and a histamine-2 receptor blocking anti-secretory agent.
REFERENCES:
patent: 4148912 (1979-04-01), Vincent et al.
patent: 4333922 (1982-06-01), Herschler
patent: 4942181 (1990-07-01), Riede
patent: 4959384 (1990-09-01), Kraft et al.
patent: 5008256 (1991-04-01), Clitherow
Ward et al., "A Double Blind Trial of the Treatment of Gastric Ulcers with a Combination of DeNol and Cimetidine", Adelaide Scientific Meeting, 1979, Programme Abstracts of Papers, Australian Mineral Foundation, Oct. 8-9; p. A30.
Goldenberg et al., "Protective Effect of Pepto-Bismol Liquid on the Gastric Mucosa of Rats", Gastroenterology, 69(3), pp. 636-640 (1975).
Vantrappen et al., "Randomized Open Controlled Trial of Colloidal Bismuth Subcitrate Tablets and Cimetidine in the Treatment of Duodenal Ulcers", Gut, 21(4), pp. 329-333 (1980).
Wieriks et al., "Pharmacological Properties of Colloidal Bismuth Subcitrate (CBS, DE-NOL.RTM.)", Scand. J. Gastroenterol., 17, Supplement 80, pp. 11-16 (1982).
Koo et al., "Selective Coating of Gastric Ulcer by Tripotassium Dicitrato Bismuthate in the Rat", Gastroenterology, 82, pp. 864-870 (1982).
Lu et al., "Effect of Furaxon and its Analogs on Gastrointestinal Propulsion in Mice", Beijing Yixueyuan Xuebao, 15, pp. 185-187 (1983).
Marshall et al., "Unidentified Curved Bacilli in the Stomach of Patients with Gastritis and Peptic Ulceration", Lancet, 1, pp. 1311-1315 (Jun. 16, 1984).
McLean et al., "Microbes, Peptic Ulcer and Relapse Rates with Different Drugs", Lancet, 2, pp. 525-526 (Sep. 1, 1984).
Hislop et al., "Histological Improvement of Active Chronic Gastritis in Patients Treated with De-Nol", Australia and New Zealand Journal of Medicine, 14, p. 907 (1984).
Lam et al., "Randomised Crossover Trial of Tripotassium Dicitrato Bismuthate Versus High Dose Cimetidine for Duodenal Ulcers Resistant to Standard Dose of Cimetidine", Gut, 25, pp. 703-706 (1984).
Zeng Zhi-Tian et al., "Double-Blind Short-Term Trial of Furazolidone in Peptic Ulcer", Lancet, 1, pp. 1048-1049 (May 4, 1985).
Piper, "Bacteria, Gastritis, Acid Hyposecretion and Peptic Ulcer", The Medical Journal of Australia, 142, p. 431 (1985).
Pinkard et al., "Campylobacter-Like Organisms From the Human Stomach--Detection, Characterization, and In Vitro Susceptibilities", Campylobacter III (Pearson et al., editors; 1985), 171-172.
Goodwin et al., "The Association of Campylobacter Pyloridis with Gastritis, and Its In Vitro Sensitivity to Antibiotics and Anti-Ulcer Agents", Australia and New Zealand Journal of Medicine, 15, (1 Supplement 1), p. 153 (1985).
Lambert et al., "Campylobacter-Like Organisms (CLO)--In Vivo and In Vitro Susceptibility to Antimicrobial and Anti-Ulcer Therapy", Gastroenterology, 88, p. 1462 (1985).
McNulty et al., "Successful Therapy of Campylobacter Pyloridis Gastritis", Gastroenterology, 90, p. 1547 (1986).
Goodwin et al., "The Minimum Inhibitory and Bactericidal Concentrations of Antibiotics and Anti-Ulcer Agents Against Campylobacter Pyloridis", Journal of Antimicrobial Chemotherapy, 17, pp. 309-314 (1986).
Hirschl et al., "Sensitivity of Campylobacter Pyloridis to Antimicrobials and Anti-Ulcer Drugs", Z. Antimikrob Antineoplast. Chemother., 4 (2), pp. 45-49 (1986).
Salmon, "Combination Treatment: Colloidal Bismuth Subcitrate with H.sub.2 -Antagonist", Digestion, 37, pp. 42-46 (1987).
U.S. Pat. Ser. No. 07/821,244 filed Jan. 10, 1992.
Peterson et al., Gastroenterology, 1979, 77, 1015-1020.
Martin et al., The Lancet, 1981, 7-10.
Gut, 1992, vol. 33, pp. 179-183.
Gut, 1984, 25, pp. 697-702.
Pharmac. Ther., 1984, 26, pp. 221-234.
Letter by M. C. Brooks dated 11 Jun. 1991, during examination of European Patent No. 206,626.
Letter by J. L'Helgoualch dated 8 Dec. 1992, during examination of European Patent Application No. 88200396.5, Publication No. 282,131.
Deutsche Med. Wochenschrift, vol. 112, No. 37, Sep. 1987, pp. 1407-1411.
Wiener Klinische Wochenschrift, vol. 99, No. 14, 17 Jul. 1987, pp. 493-497.
Chemical Abstracts, vol. 107, No. 5, 34d Aug. 1987, p. 397, Abstract No. 36471w.
Fay Zohreh
Mohl Douglas C.
Rasser Jacobus C.
The Procter & Gamble & Company
Zerby Kim William
LandOfFree
Compositions and methods for treating gastrointestinal disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating gastrointestinal disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating gastrointestinal disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-65250